Medifast, Inc. (MED)
NYSE: MED · Real-Time Price · USD
12.18
+0.02 (0.16%)
At close: Aug 28, 2026, 4:00 PM EDT
12.35
+0.17 (1.40%)
After-hours: Aug 28, 2026, 7:56 PM EDT
Medifast Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 126 | 110 | 188 | 724 | 1,253 | 2,424 | |
Market Cap Growth | -19.64% | -41.52% | -74.09% | -42.20% | -48.30% | 5.36% |
Enterprise Value | -16 | -51 | 35 | 589 | 1,211 | 2,284 |
Last Close Price | 12.18 | 10.68 | 17.62 | 67.22 | 109.01 | 188.97 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | 89.76 | 7.29 | 8.73 | 14.78 |
Forward PE | - | 53.77 | 38.00 | 13.05 | 9.03 | 13.75 |
PS Ratio | 0.40 | 0.28 | 0.31 | 0.68 | 0.78 | 1.59 |
PB Ratio | 0.64 | 0.55 | 0.89 | 3.60 | 8.08 | 11.97 |
P/TBV Ratio | 0.64 | 0.55 | 0.89 | 3.60 | 8.08 | 11.97 |
P/FCF Ratio | 31.38 | 87.88 | 11.03 | 5.13 | 7.05 | 40.17 |
P/OCF Ratio | 14.32 | 15.99 | 7.67 | 4.91 | 6.44 | 25.64 |
PEG Ratio | - | 0.55 | 0.55 | 0.55 | 0.55 | 0.55 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | - | - | 0.06 | 0.55 | 0.76 | 1.50 |
EV/EBITDA Ratio | - | - | 1.26 | 4.22 | 6.19 | 10.24 |
EV/EBIT Ratio | - | - | 2.30 | 4.66 | 6.55 | 10.56 |
EV/FCF Ratio | - | - | 2.08 | 4.17 | 6.81 | 37.85 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.14 | 0.05 | 0.08 | 0.11 | 0.17 | 0.16 |
Debt / EBITDA Ratio | - | 2.17 | 0.49 | 0.15 | 0.13 | 0.14 |
Debt / FCF Ratio | 6.88 | 8.56 | 0.95 | 0.16 | 0.15 | 0.54 |
Net Debt / Equity Ratio | -0.72 | -0.79 | -0.70 | -0.63 | -0.40 | -0.38 |
Net Debt / EBITDA Ratio | 25.12 | -5399.28 | -5.21 | -0.92 | -0.31 | -0.34 |
Net Debt / FCF Ratio | -35.44 | -125.36 | -8.59 | -0.91 | -0.35 | -1.28 |
Asset Turnover | 1.20 | 1.45 | 2.03 | 3.42 | 4.47 | 4.53 |
Inventory Turnover | 3.79 | 3.53 | 3.25 | 3.42 | 3.07 | 3.41 |
Quick Ratio | 4.09 | 3.89 | 2.53 | 1.63 | 0.62 | 0.65 |
Current Ratio | 4.86 | 4.69 | 3.34 | 2.43 | 1.58 | 1.81 |
Return on Equity (ROE) | -12.42% | -9.13% | 1.02% | 55.77% | 80.31% | 91.20% |
Return on Assets (ROA) | -4.60% | -3.34% | 3.24% | 25.24% | 32.33% | 40.08% |
Return on Invested Capital (ROIC) | -39.40% | -26.76% | 12.37% | 116.95% | 131.72% | 274.89% |
Return on Capital Employed (ROCE) | -8.90% | -6.90% | 7.00% | 58.10% | 105.40% | 94.60% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | -20.33% | -17.01% | 1.11% | 13.72% | 11.46% | 6.77% |
FCF Yield | 3.19% | 1.14% | 9.07% | 19.49% | 14.19% | 2.49% |
Dividend Yield | - | - | - | 7.36% | 6.02% | 3.01% |
Payout Ratio | - | - | 34.19% | 73.45% | 49.89% | 38.93% |
Buyback Yield / Dilution | -0.27% | -0.16% | -0.39% | 3.15% | 4.55% | 0.31% |
Total Shareholder Return | -0.27% | -0.16% | -0.39% | 10.51% | 10.56% | 3.32% |